Related Experiment Video
Updated: Sep 29, 2025
07:27
The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
Published on: October 21, 2017
11.9K
The Role of Catecholamines in Pathophysiological Liver Processes.
Elise Lelou1, Anne Corlu1, Nicolas Nesseler1,2
1INSERM, Université Rennes, INRAE, Institut NuMeCan, Nutrition, Metabolisms and Cancer, F-35000 Rennes, France.
Cells
|March 25, 2022
Summary
Catecholamines (epinephrine, norepinephrine, dopamine) impact liver health, influencing diseases like fibrosis and cancer. Understanding these mechanisms may enable new therapeutic uses for existing drugs.
Area of Science:
- Hepatology
- Endocrinology
- Pharmacology
Background:
- Research on catecholamines' role in liver disease is growing.
- Mechanisms linking catecholamines to liver conditions remain unclear.
- The liver interacts with and metabolizes catecholamines.
Purpose of the Study:
- To review catecholamine involvement in liver physiology and pathophysiology.
- To explore the expression of adrenergic and dopaminergic receptors in liver cells.
- To highlight potential therapeutic applications of catecholamine antagonists in liver disease.
Main Methods:
- Literature review of research on catecholamines and liver disease.
- Discussion of catecholamine-receptor interactions in liver cells.
- Analysis of catecholamine roles in metabolic and disease processes.
Main Results:
- Catecholamines influence glucose and lipid metabolism, and liver regeneration.
- They impact drug-metabolizing enzymes, sepsis-related dysfunction, fibrosis, fatty liver, and cancer.
- Liver cells express adrenergic and dopaminergic receptors.
Conclusions:
- Understanding catecholamine-liver interactions is crucial.
- Existing adrenergic and dopaminergic antagonists may offer therapeutic benefits for liver diseases.
- Further research could facilitate the use of these drugs as treatments or adjuncts.
Related Concept Videos
01:30Liver Physiology
1.5K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
1.5K
01:24Liver Regeneration
3.4K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.4K
01:25cAMP-dependent Protein Kinase Pathways
6.7K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.7K
01:25Adrenergic Agonists: Indirect-Acting Agents
2.0K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.0K
01:27Adrenergic Neurons: Neurotransmission
4.4K
Postganglionic sympathetic fibers (except those supplying the sweat glands) releasing noradrenaline or norepinephrine are called noradrenergic or adrenergic neurons. Noradrenaline, dopamine, adrenaline, or epinephrine are collectively called "catecholamines" as they contain a catechol moiety and an amine side chain. The five stages of neurotransmitter release involve their synthesis, storage, release, reuptake and metabolism.
Synthesis: Catecholamine synthesis requires tyrosine, which...
Synthesis: Catecholamine synthesis requires tyrosine, which...
4.4K
01:29Drugs Affecting Neurotransmitter Synthesis
1.6K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.6K